Detalhe da pesquisa
1.
CALR mutation burden in essential thrombocythemia and disease outcome.
Blood
; 143(13): 1310-1314, 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38252902
2.
Advanced systemic mastocytosis-Revised classification, new drugs and how we treat.
Br J Haematol
; 204(2): 402-414, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38054381
3.
Autoimmune myelofibrosis: A Mayo Clinic series of 22 patients.
Br J Haematol
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38698680
4.
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).
Br J Haematol
; 204(4): 1243-1248, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38083865
5.
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
Br J Haematol
; 204(4): 1232-1237, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38311378
6.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36130297
7.
Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
Haematologica
; 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38450522
8.
Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.
Haematologica
; 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38299584
9.
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.
Haematologica
; 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38546692
10.
New drugs in myelofibrosis: Critical assessment of additional value to monotherapy with JAK inhibitors.
Am J Hematol
; 99(5): 978-981, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38332640
11.
Venetoclax in the treatment of acute myeloid leukemia: Beyond VIALE-A.
Am J Hematol
; 99(4): 515-518, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38375926
12.
Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all?
Am J Hematol
; 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38752361
13.
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
Am J Hematol
; 99(6): 1142-1165, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38450850
14.
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Am J Hematol
; 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38644693
15.
Risk models in myelofibrosis-the past, present, and future.
Am J Hematol
; 99(4): 519-522, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38400565
16.
Momelotinib expands the therapeutic armamentarium for myelofibrosis: Impact on hierarchy of treatment choices.
Am J Hematol
; 99(2): 300-308, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38164985
17.
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Am J Hematol
; 99(4): 697-718, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38269572
18.
Incidental discovery of KIT-mutated mastocytoma in a colon polyp.
Am J Hematol
; 99(5): 973-974, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38270251
19.
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
Am J Hematol
; 99(1): 21-27, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37772442
20.
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
Am J Hematol
; 99(1): E1-E4, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37688525